High resolution structures of highly bulged viral Epitopes bound to major histocompatibility complex class I - Implications for T-cell receptor engagement and T-cell immunodominance

被引:133
作者
Tynan, FE
Borg, NA
Miles, JJ
Beddoe, T
El-Hassen, D
Silins, SL
van Zuylen, WJM
Purcell, AW
Kjer-Nielsen, L
McCluskey, J
Burrows, SR
Rossjohn, J [1 ]
机构
[1] Queensland Inst Med Res, Cellular Immunol Lab, Brisbane, Qld 4029, Australia
[2] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia
[3] Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Prot Crystallog Unit, Clayton, Vic 3800, Australia
基金
英国惠康基金;
关键词
D O I
10.1074/jbc.M503060200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Although HLA class I alleles can bind epitopes up to 14 amino acids in length, little is known about the immunogenicity or the responding T-cell repertoire against such determinants. Here, we describe an HLA-B*3508-restricted cytotoxic T lymphocyte response to a 13-mer viral epitope (LPEPLPQGQLTAY). The rigid, centrally bulged epitope generated a biased T-cell response. Only the N-terminal face of the peptide bulge was critical for recognition by the dominant clonotype SB27. The SB27 public T-cell receptor (TcR) associated slowly onto the complex between the bulged peptide and the major histocompatibility complex, suggesting significant remodeling upon engagement. The broad antigen-binding cleft of HLA-B*3508 represents a critical feature for engagement of the public TcR, as the narrower binding cleft of HLA-B*3501(LPEPLPQGQLTAY), which differs from HLA-B*3508 by a single amino acid polymorphism (Arg(156) -> Leu), interacted poorly with the dominant TcR. Biased TcR usage in this cytotoxic T lymphocyte response appears to reflect a dominant role of the prominent peptide(.)major histocompatibility complex class I surface.
引用
收藏
页码:23900 / 23909
页数:10
相关论文
共 79 条
[1]   How selective is the transporter associated with antigen processing? [J].
Androlewicz, MJ ;
Cresswell, P .
IMMUNITY, 1996, 5 (01) :1-5
[2]   DOMINANT SELECTION OF AN INVARIANT T-CELL ANTIGEN RECEPTOR IN RESPONSE TO PERSISTENT INFECTION BY EPSTEIN-BARR-VIRUS [J].
ARGAET, VP ;
SCHMIDT, CW ;
BURROWS, SR ;
SILINS, SL ;
KURILLA, MG ;
DOOLAN, DL ;
SUHRBIER, A ;
MOSS, DJ ;
KIEFF, E ;
SCULLEY, TB ;
MISKO, IS .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (06) :2335-2340
[3]   USE OF SYNTHETIC PEPTIDES OF INFLUENZA NUCLEOPROTEIN TO DEFINE EPITOPES RECOGNIZED BY CLASS-I-RESTRICTED CYTOTOXIC LYMPHOCYTES-T [J].
BASTIN, J ;
ROTHBARD, J ;
DAVEY, J ;
JONES, I ;
TOWNSEND, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 165 (06) :1508-1523
[4]  
Bertoni R, 1998, J IMMUNOL, V161, P4447
[5]  
BLUESTONE JA, 1986, J IMMUNOL, V137, P1244
[6]   The CDR3 regions of an immunodominant T cell receptor dictate the 'energetic landscape' of peptide-MHC recognition [J].
Borg, NA ;
Ely, LK ;
Beddoe, T ;
Macdonald, WA ;
Reid, HH ;
Clements, CS ;
Purcell, AW ;
Kjer-Nielsen, L ;
Miles, JJ ;
Burrows, SR ;
McCluskey, J ;
Rossjohn, J .
NATURE IMMUNOLOGY, 2005, 6 (02) :171-180
[7]   Stable, soluble T-cell receptor molecules for crystallization and therapeutics [J].
Boulter, JM ;
Glick, M ;
Todorov, PT ;
Baston, E ;
Sami, M ;
Rizkallah, P ;
Jakobsen, BK .
PROTEIN ENGINEERING, 2003, 16 (09) :707-711
[8]  
Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
[9]   CD8+ T-cell selection, function, and death in the primary immune response in vivo [J].
Callan, MFC ;
Fazou, C ;
Yang, HB ;
Rostron, T ;
Poon, K ;
Hatton, C ;
McMichael, AJ .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (10) :1251-1261
[10]   PREFERENTIAL EXPRESSION OF THE HUMAN V-BETA-7.1 GENE SEGMENT ON CD5+ PERIPHERAL-BLOOD LYMPHOCYTES [J].
CALLAN, MFC ;
GILLESPIE, GM ;
REYBURN, HT ;
MOSS, PAH ;
BELL, JI ;
MCMICHAEL, AJ .
T-CELL RECEPTOR USE IN HUMAN AUTOIMMUNE DISEASES, 1995, 756 :94-95